KDR and major depressive disorder: Therefore, pharmacological modulation of VEGF receptors could have efficacy in MDD, consistent with the recent finding that neuronal VEGF-VEGFR2 (Flk-1) pathways play a key role in the rapid antidepressant actions of ketamine (Deyama et al., 2019b).